Thursday, March 23, 2017

greeksprepareto march to liberate the nassau otb

faithful and seethat while they snd the romsn catholics observe on sunday apri 26 the nassau otb faithful may work and or bet and or pray

Claude Solnik
Long Island Business News
2150 Smithtown Ave.
Ronkonkoma, NY 11779-7348 

Home > LI Confidential > Stop scratching on holidays

Stop scratching on holidays
Published: June 1, 2012


Off Track Betting in New York State has been racing into a crisis called shrinking revenue. Some people have spitballed a solution: Don’t close on holidays.
New York State Racing Law bars racing on Christmas, Easter and Palm Sunday, and the state has ruled OTBs can’t handle action on those days, even though they could easily broadcast races from out of state.
“You should be able to bet whenever you want,” said Jackson Leeds, a Nassau OTB employee who makes an occasional bet. He added some irrefutable logic: “How is the business going to make money if you’re not open to take people’s bets?”
Elias Tsekerides, president of the Federation of Hellenic Societies of Greater New York, said OTB is open on Greek Orthodox Easter and Palm Sunday.
“I don’t want discrimination,” Tsekerides said. “They close for the Catholics, but open for the Greek Orthodox? It’s either open for all or not open.”
OTB officials have said they lose millions by closing on Palm Sunday alone, with tracks such as Gulfstream, Santa Anita, Turf Paradise and Hawthorne running.
One option: OTBs could just stay open and face the consequences. New York City OTB did just that back in 2003. The handle was about $1.5 million – and OTB was fined $5,000.
Easy money.



Placeholder image 
Placeholder image

Ivan Savvidis

Member of the Presidential Council of International Relations, President of the National Cultural Autonomy of Greeks in Russia, Coordinator of the World Council of Hellenes Abroad (SAE) of the countries of the Former Soviet Union, Founder and Chairman of the Board of Directors of «Agrocom Group» Holding Company, an outstanding philanthropist. BIOGRAPHY Ivan Savvidi, Greek by birth, was born on 27th of March 1959 in the Greek settlement of Georgian Soviet Socialist Republic, eighth child in a family of worker. After finishing secondary school in the Rostov region, he went to serve in Soviet Army, and quit the army in the rank of sergeant major. In1980 he came to the Rostov Tobacco Factory. In 1988 Ivan Savvidi graduated from the logistic faculty of Rostov State University of Economics. In 1993 he was elected as a General Director of the Company «Donskoy Tabak». In 1998 Ivan Savvidi started his political path, and up to 2003 was Member of Legislative Assembly of the Rostov region. In December 2003 Ivan Savvidi was elected as the State Duma Member of 4th convocation. Since April 2004 he was the Vice-chairman of Budget and Taxation Committee. In April 2007 Ivan Savvidi was reelected in Russian Federation State Duma, where he



























was a Member of Committee of International Affairs and Coordinator of Interparliamentary Deputy Group by Relations with Parliament of Greek Republic, Vice-chairman of the Commission of Parliament Assembly Of Russia and Belorussia Union by External Politics, member of PACE. Since 2012 Ivan Savvidi holds the position of the Chairman of the Board of Directors of the «Agrocom Group» Holding Company, founded in 2004. Ivan Savvidi is engaged in social activities, holds the position of the president of the National Cultural Autonomy of Russian Greeks, Coordinator of the World Council of Hellenes Abroad (SAE) of the countries of the Former Soviet Union. Since 2012 he is a Member of the Presidential Council of International Relations. In 2013 he was awarded the status of the Honourable citizen of Greece for his special role and contribution into development of relations between Russia and Greece, merits to Greek nation, Greek republic, world Orthodoxy, public and philanthropic activities. Ivan Savvidi adheres to the socially conscious position, he is a founder of Charitable Foundation that launches programs aimed at spiritual revival and restoration of Orthodox shrines, creative development of youth, promotion of healthy lifestyle, cultural, educational, scientific and research projects. Annual volume of charitable payments makes more than 2, 5 million EURO. Ivan Savvidi's achievements in public, social and economic activities and his contribution to social and economic development of Russia were honored by several national awards such as Medal of the Order of Merit for the Motherland, Medal of Honor, awards of Russian Orthodox Church, Presidential letters of gratitude etc. Ivan Savvidi is a candidate of economic science, has several works on logistic and marketing. Married, has two sons. 

       


Sunday, April 16, 2017
Track CodeTrack NameEntryScratch1st Post
ET
1st Post
Local
Time
Zone
Stakes Race(s)Stakes GradeT.V.
Indicator
EMDEMERALD DOWNS72245:00 PM2:00 PMPDT
GGGOLDEN GATE FIELDS48243:45 PM12:45 PMPDT
GPGULFSTREAM PARK7201:15 PM1:15 PMEDT
LRLLAUREL PARK72012:30 PM12:30 PMEDT
SASANTA ANITA PARK72243:30 PM12:30 PMPDT
SUNSUNLAND PARK168243:30 PM1:30 PMMDTSunland Park H.
Copper Top Futurity
WOWOODBINE72481:00 PM1:00 PMEDT




Placeholder image

George D. Yancopoulos, M.D. Ph. D.

President of Regeneron Laboratories & Chief Scientific Officer Regeneron Pharmaceuticals Tarrytown, NY Dr. Yancopoulos graduated as valedictorian of both the Bronx High School of Science and Columbia College, and then earned his MD & PhD degrees at Columbia University’s College of Physicians and Surgeons. Dr. Yancopoulos left academia in 1989 to become scientific founder of Regeneron Pharmaceuticals, where he is President of Regeneron Laboratories and Chief Scientific Officer. Dr. Yancopoulos is a rare individual who has not only built one of the world’s “top ten” biotech companies from the ground up (working together with his long-time friend and partner, Dr. Len Schleifer, who is CEO of Regeneron), but simultaneously been recognized as a world-class basic science researcher, while also inventing some of the most valuable technologies and FDA-approved drugs in the industry. Dr. Yancopoulos has authored more than 350 scientific manuscripts, and, according to a study by the Institute for Scientific Information, was the eleventh most highly cited scientist in the world during the 1990’s. In 2004, he was elected to both the National Academy of Sciences and the American Academy of Sciences. Working with his team at Regeneron, Dr. Yancopoulos holds almost 100 patents, including for Regeneron’s foundational platforms for target and drug discovery such as Trap Technology, VelociGene® (which was utilized by the NIH for its $50M “Knock-Out the Mouse Genome Project”) and VelocImmuneTM (which is arguably one of the most valuable biotechnologies ever invented, having already generated more than $2.5B in licensing and collaboration revenues). Dr. Yancopoulos is also a principal inventor and developer of Regeneron’s three FDA-approved drugs, including EYLEA® (VEGF Trap-Eye, a new treatment for age-related macular degeneration), ZALTRAP® (VEGF Trap-Onc, for colorectal cancer), and ARCALYST® (the IL1-Trap, for orphan inflammatory disease). EYLEA® has already achieved blockbuster status, with one of the largest first-full year launches in biotech history. Dr. Yancopoulos’ team has recently progressed several fully human monoclonal antibodies (derived using his VelocImmuneTM platform) into advanced human trials for various indications, including cholesterol-lowering, rheumatoid arthritis, allergic asthma and atopic dermatitis. 

       
Sunday, April 16, 2017
Track CodeTrack NameEntryScratch1st Post
ET
1st Post
Local
Time
Zone
Stakes Race(s)Stakes GradeT.V.
Indicator
EMDEMERALD DOWNS72245:00 PM2:00 PMPDT
GGGOLDEN GATE FIELDS48243:45 PM12:45 PMPDT
GPGULFSTREAM PARK7201:15 PM1:15 PMEDT
LRLLAUREL PARK72012:30 PM12:30 PMEDT
SASANTA ANITA PARK72243:30 PM12:30 PMPDT
SUNSUNLAND PARK168243:30 PM1:30 PMMDTSunland Park H.
Copper Top Futurity
WOWOODBINE72481:00 PM1:00 PMEDT

Our 2017 Greek Independence parade sponsors

Click on the logos 
Placeholder image

No comments:

Post a Comment